Introduction {#sec1}
============

Infectious bronchitis virus (**IBV**) is a *Gammacoronavirus* that belongs to the family *Coronaviridae* and has a positive sense single stranded 27.6 kb RNA genome ([@bib9]). The 1a and 1b open reading frames (**ORFs**) encode the 1ab polyprotein using a ribosomal frameshift event at the end of ORF1a. The large 1ab polyprotein is then post-translationally cleaved into 15 non-structural polypeptides, which are required for RNA replication and translation. The four major IBV structural proteins, including the spike (**S**) glycoprotein, small envelope (**E**) protein, membrane (**M**) glycoprotein, and nucleocapsid (**N**) protein, were encoded by ORFs 2, 3c, 4, and 6, respectively. The spike protein was further processed into the S1 and S2 subunits. The small accessory proteins, 3a, 3b, 5a, and 5b, which are not essential for viral replication ([@bib11]), are encoded by ORF 3a, 3b, 5a, and 5b, respectively. The viral genome, especially the S1 gene which encodes the epitopes that induce virus neutralizing antibodies ([@bib12]), can evolve rapidly by mutation and/or recombination events, resulting in the occurrence of an array of different serotypes, genotypes/lineages, and variants. Thus, IBV strain classification and evolutionary analysis are typically accomplished by the phylogenetic analysis of the complete coding region of the S1 subunit.

The use of vaccination remains the most effective method for the prevention and control of infectious bronchitis (**IB**) to date. Live-attenuated vaccines were developed and used to protect chickens in an attempt to minimize the economic effects caused by IBVs ([@bib45]). In addition, less attenuated strains, at a lower passage level in embryonated eggs (e.g., H52), were used to revaccinate future layers or breeders prior to the onset of lay ([@bib8]), albeit they are liable to cause disease ([@bib8]; [@bib3]). In general, a vaccine provides good clinical protection, and vaccination can be efficacious for protecting birds from IBV infection. However, outbreaks of IB-associated diseases occur frequently in vaccinated flocks throughout the world, which are caused by variable or poor cross-protection due to antigenic differences between the vaccine and field strain. With respect to the vaccine, it has been shown that the vaccine strains have a high relative risk, meaning that more cases of IB associated with the vaccine strain are observed than expected ([@bib2]).

The recent comprehensive classification of phylogenetic analysis based on the complete S1 genes divided IBV strains in 36 lineages grouped in 7 genotypes (GI-1∼GI-29, GII-1, GII-2, GIII-1∼GVII-1), and a number of inter-lineage recombinants throughout the world ([@bib43]; [@bib15]; [@bib23]; [@bib32]; [@bib37]). The Massachusetts (Mass) type IBV, coupled with the Connecticut (Conn) serotype in the GI-1 lineage ([@bib43]), have been widely circulating worldwide for decades since the first description in 1931 ([@bib42]). The Mass type H120 vaccine virus has been successfully used worldwide as a primary vaccine in broilers for almost 50 years ([@bib8]). China also includes Mass type strains in its vaccination program; recently, the use of other strains, such as LDT3-A strain ([@bib20]), has been officially authorized. However, a number of Mass type IBV strains were isolated from vaccinated chicken flocks ([@bib30]; [@bib14]). In addition, some of these strains were proposed to have been derived from recombination events between Mass-type IBVs, as well as between Mass type and other IBV types circulating in China ([@bib30]; [@bib28]; [@bib14]). The isolated viruses had not exhibited extensive mutations with regards to both the S1 gene and complete genomic sequences of the H120 or M41 strains ([@bib30]; [@bib14]).

In the course of surveillance of IBV, we isolated four IBV strains from chicken flocks suspected to be infected with IBV in northeast China between 2013 and 2017. Classification based on the complete S1 sequence phylogenetic analysis has grouped the four isolates into GI-1/Mass lineage. In order to investigate the origin and evolution of the four GI-1/Mass lineage viruses, the complete genomic sequences of the four isolates were determined in this study. In addition, the other phenotypic characterization, including antigenicity, pathogenicity and protective efficiency of H120 vaccine against one of the isolate I1124/16 was evaluated in specific pathogen-free (**SPF**) chicks by vaccination-challenge test.

Materials and Methods {#sec2}
=====================

Ethics {#sec2.1}
------

This study was conducted in accordance with the animal welfare guidelines of the World Organization for Animal Health. All animal protocols were reviewed and approved by the Agricultural Animal Care and Use Committee of Heilongjiang province, China.

Virus isolation, propagation and titration {#sec2.2}
------------------------------------------

Four field strains were isolated in this study. Strains ck/CH/LJL/130906 (**LJL/130906**) and ck/CH/LJL/140820 (**LJL/140820**) were isolated from the trachea of a 28-day-old layer in 2013 and the proventriculus of a 23-day-old layer in 2014 in Jilin province. Strains I1124/16 and I0306/17 were isolated in 2016 and 2017 from laying hens in Liaoning and Heilongjiang provinces in China, respectively ([@bib47]). All the chicken flocks have been vaccinated with the Mass-type live-attenuated vaccine H120 strain ([@bib8]) at one day of age and boosted at 15 to 20 days. All the birds from which the viruses were isolated suffered respiratory signs.

The Mass-type live-attenuated vaccine H120 strain and the Mass-type pathogenic M41 strain ([@bib14]) were also used in this study. Strains H120, M41, and four field isolates were used for complete genome sequencing and in the virus neutralization (**VN**) test. Isolate I1124/16 and strains H120 and M41 were used in the vaccination-challenge test. All of the viruses were passaged additional time in nine-day-old SPF chicken embryonated eggs to prepare the viral stocks. The viruses were titrated as previously described ([@bib20]). Virus titers were calculated using the [@bib39] method and expressed as the 50% embryo infectious dose (**EID** ~**50**~).

RNA extraction, RT-PCR, sequencing, and genomic sequence determination {#sec2.3}
----------------------------------------------------------------------

The complete genomic sequences of H120, M41, and the four field strains, LJL/130906, LJL/140820, I1124/16, and I0306/17 were determined. The RNA was extracted from the allantoic fluids using an RNAiso Plus kit (Takara Bio Inc., Shiga, Japan) in accordance with the manufacturer's protocol. RT-PCR was performed using a one-step RT-PCR kit (Takara Bio Inc.), according to the manufacturer's instructions, with primers previously designed for IBV full genome sequencing ([@bib30]). The 3′/5′ termini of each IBV strain were determined using 3′ /5′ RACE protocols, as previously described ([@bib30]). Each genome fragment was sequenced at least three times.

Chromatograms were analyzed using the program, Chromas (<http://technelysium.com.au/wp/chromas/>), the resulting complete genomic sequence of each virus was determined, aligned, and the ORFs were determined using BioEdit (<http://www.mbio.ncsu.edu/bioedit/bioedit.html>) based on the genomic sequence of the Massachusetts (GQ504724) strains.

S1 subunit of the spike protein sequence analysis {#sec2.4}
-------------------------------------------------

To download all available IBV GI-1/Mass-type complete S1 gene sequences in the GenBank database (National Center for Biotechnology Information, <http://www.ncbi.nlm.nih.gov/>), the S1 gene sequences of the H120 and M41 strains in this study were entered into the BLASTn program (<http://www.ncbi.nlm.nih.gov/BLAST/>). All sequences with a genetic distance higher than 95% were downloaded (equal or lower than 95% were Connecticut strains and other IBV types). In total, 275 GI-1/Mass-type complete S1 gene sequences were obtained, and were merged with those of our 4 field isolates, one vaccine strain and one pathogenic M41 strain. The S1 sequence of ck/CH/LDL/091022 (**LDL/091022**) was used as an outgroup. Of the 275 GI-1/Mass-type sequences, 140 were obtained from China, 49 from USA, 27 from India, 12 from Brazil, 11 from Sweden, six each from Iran and Thailand, five from Korea, three each from Canada and Egypt, two each from Poland, South Africa and Spain, and one sequence each from Japan, Jordan, Israel, Malaysia, Netherlands, Pakistan, Saudi Arabia, and UK. The nucleotide and the deduced amino acid sequences were generated using MegAlign program implemented in DNAStar (<https://www.dnastar.com/software/lasergene/>) ([@bib10]), and phylogenetic trees were constructed via the maximum-likelihood and maximum parsimony methods, respectively, with 1000 bootstrap replicates using MEGA 6.0 ([http://www.megasoftware.net/](http://www.megasoftware.net/index.html){#intref0035}). The detected strains were classified as vaccines when they were identical or closely related (p-distance \<0.01) to one of the administered vaccine ([@bib46]; [@bib26]). Hence, the S1 nucleotide and amino acid sequences of our four isolates were compared pairwise with those of the vaccine and M41 strains, and the p-distance was calculated via the Clustal W method in MegAlign program between our four field strains, vaccine strains, and M41 strain to clarify their genetic relationship with the reference IBV strains.

Complete genomic sequence analysis {#sec2.5}
----------------------------------

The BLASTn program was used to search GenBank for similar IBV sequences using the complete genomic sequences of the H120 and M41 strains in this study. All sequences with a genetic distance higher than 95% were downloaded (equal or lower than 95% were Connecticut and other IBV types). A total of 69 complete genomic sequences were obtained and merged with those of our six IBV strains and that of strain LDL/091022, which was used as a reference strain. Of the 69 sequences, 46 were obtained from China, 10 from USA, four from Brazil, three from India, two from Canada, and one from Egypt, Jordan, Pakistan, and UK. The MegAlign program implemented in DNAStar was used to align sequences and calculate the percent identity between the selected sequences. Phylogenetic trees were constructed using the above-mentioned methods.

To identify the genetic relationship among the GI-1/Mass-type viruses, the complete genomic sequences of our six IBV strains were compared to those of strains in the H120- and M41-clade based on the phylogenetic results of complete genomic sequences using Multiple Alignment with Fast Fourier Transformation (**MAFFT**) version v6 (<http://mafft.cbrc.jp/alignment/software/>) and Similarity plot (**SimPlot**) version 3.5.1 (<http://sray.med.som.jhmi.edu/SCRopftware/simplot/>) ([@bib31]). The window width and step size in SimPlot were set to 500 bp and 50 bp, respectively. The complete genomic sequence of our H120 vaccine strain was used as a query.

The sequence fragments of the LJL/130906 and I1124/16 strains, which exhibited obvious diversity to those of our M41 strain by MAFFT and SimPlot, were then submitted to a BLAST search in the NCBI database to identify homologous sequences. The sequence of Conn-type virus (Connecticut vaccine) displayed higher close genetic relationships with the LJL/130906 in region III. Therefore, the complete genomic sequences of the Connecticut vaccine were used to further analyze the recombination events that possibly occurred in the genome of the LJL/130906 strain using SimPlot and bootscan analyses. The complete genomic sequences of our four isolates were also compared pairwise with those of the H120, Ma5 and M41 strains, and the percent identities were calculated.

Accession numbers {#sec2.6}
-----------------

The complete genomic sequences of the H120, M41, LJL/130906, LJL/140820, I1124/16, and I0306/17 strains in this study have been deposited in the GenBank database under the following accession numbers: H120, MK937831; M41, MK937830; LJL/130906, MK937832; LJL/140820, MK937833; I1124/16, MK937828; and I0306/17, MK937829.

Virus neutralization test {#sec2.7}
-------------------------

To prepare hyperimmune sera for the VN assay, twenty-four one-month-old SPF layers were randomly divided into six groups consisting of four birds per group, and housed in separate isolators. The birds in each group were inoculated with strains H120, M41, LJL/130906, LJL/140820, I1124/16, and I0306/17 via the oculonasal route at a dose of 10^5^ EID~50~ in 0.1 mL volume per chick. At two weeks post inoculation, the birds in each group received an intravenous injection of the same dose of the corresponding virus. After another two weeks, the blood was collected and the serum was harvested and pooled for each group, inactivated at 56°C for 30 min and stored at -70°C until further use.

To determine the antigenic relationship between the six Mass-type IBV strains, cross virus neutralization tests, with a fixed concentration of virus and serial dilutions of serum, were performed ([@bib14]). The R values were calculated by the method described by [@bib6]. The tests were performed in the presence of appropriate controls. The antigenic difference between two given strains was defined as follows: an R value of 100% or close to 100% indicates viruses that are antigenically identical between two tested viruses, an R value \>70% indicates little or no difference, an R value between 33% and 70% indicates a minor subtype difference, an R value between 11% and 32% indicates a major subtype difference, and an R value between 0% and 10% indicates different serotypes ([@bib16]).

Vaccination-challenge test {#sec2.8}
--------------------------

The protocols for the animal experiments were approved by the Animal Welfare Committee of Heilongjiang Province, China. Five groups of 10 one-day-old SPF White Leghorn chicks were used. Birds in groups 1 and 3 were experimentally vaccinated via the intraocular and intranasal routes with 0.1 ml of H120 vaccine (10^4.0^ EID~50~/bird) (Zegpi et al., 2020). Birds in groups 2, 4 and 5 were mock-infected with SPF allantoic fluids and maintained under the same conditions. Blood samples were collected from each group at 4, 8, 12, 16 and 20 days of age. At 21 days, the chicks in groups 1 and 2 were experimentally infected with isolate I1124/16 and in groups 3 and 4 with M41 strain via the intraocular and intranasal routes at a dose of 10^5^ EID~50~ in 0.1 mL volume per chick. Birds in group 5 were mock-infected with SPF allantoic fluids and used as negative control. Each of the birds were marked and signs of virus effects ([@bib41]), such as listlessness, huddling, and ruffled feathers, were investigated twice daily and recorded. Signs were scored as 0 (absent), 1 (mild), 2 (moderate), 3 (severe), and 4 (death). Clinical signs were investigated and recorded daily until 25 days post infection (dpi). The most severe clinical signs of each bird was used to calculate the mean score. Blood and tracheal samples were collected from the birds in each group at 4, 8, 12, 16, 20 and 24 dpi. Blood samples were used for antibody detection (ELISA; IDEXX Corporation, Westbrook, ME) in accordance with the manufacturer\`s instructions. To assess the protection efficiency, the tracheal samples were used for virus recovery using nine-day-old SPF chicken embryonated eggs ([@bib29]).

Results {#sec3}
=======

S1 gene characteristics of the four field IBV strains {#sec3.1}
-----------------------------------------------------

The S1 nucleotide sequences of the I2214/16 and I0306/17 strains were the same as previously reported ([@bib47]). The phylogenetic trees constructed using the nucleotide and amino acid sequences of the S1 subunit of the spike glycoprotein with the maximum-likelihood and maximum parsimony methods exhibited a very similar topology. Thus, the phylogenetic trees for amino acids via the maximum-likelihood method have been illustrated in this study ([Figure 1](#fig1){ref-type="fig"} A). Our four IBV isolates clustered together with the H120, Ma5, H52 and other Mass-type vaccine strains (H120-clade) ([@bib27]), which were separate from M41 (M41-clade). Although all of the H120 vaccine strains were clustered in the same clade, they displayed amino acid substitutions compared to each other ([Supplementary Figure 1](#appsec1){ref-type="sec"}).Figure. 1Phylogenetic trees based on the complete S1 amino acid sequences of 275 GI-1/Mass-type strains, including our six strains and 269 reference strains (A) and the complete genomic sequences of 69 IBV strains, including our six strains and 63 reference strains (B). The sequences of the IBV strain, LDL/091022, was used as an outgroup. The phylogenetic trees were constructed using the maximum-likelihood with 1000 bootstrap replicates using MEGA 6.0 ([http://www.megasoftware.net/](http://www.megasoftware.net/index.html){#intref0050}). The stars indicate the vaccine strains. Our strains used in this study are shown in bold. The black squares indicate IBV strains with available complete genomes.

The p-distance of our isolates to the vaccine and M41 strains are listed in [Table 1](#tbl1){ref-type="table"} . The p-distances of strains LJL/140820 and I0306/17 to most of the Mass-type vaccine strains were lower than 0.01. The p-distances of strains LJL/140820 and I0306/17 to M41 strain were equal or higher than 0.025. These findings demonstrate that the LJL/140820 and I0306/17 strains were closely related to the vaccine. For the LJL/130906 and I1124/16 isolates, the p-distances to the H120 commercial vaccine D (a Mass-type live attenuated vaccine strain derived from H120 strain; GenBank accession no. KU736751) and Mass commercial vaccine were lower than 0.01. In contrast, the p-distances to other strains selected in this study were higher than 0.01.Table 1The *p-distances* of S1 coding region[a](#tbl1fna){ref-type="table-fn"} between our IBV isolates and the vaccine strains.StrainLJL/130906LJL/140820I1124/16I0306/17NT[b](#tbl1fnb){ref-type="table-fn"}AA[b](#tbl1fnb){ref-type="table-fn"}NTAANTAANTAAH120 (M21970-Neitherland)0.0200.0240.0020.0040.0200.0240.0010.000H120 (MK071267-Brazil)0.0210.0260.0020.0060.0210.0260.0020.002H120 commercial vaccine D (KU736751-Brazil)0.0030.0070.0180.0200.0020.0040.0200.020H120 (EU822341-China-Taiwan)0.0190.0220.0020.0060.0190.0220.0020.002H120 (FJ807652-China)0.0200.0260.0030.0090.0200.0260.0040.006H120 (MK937831-China)0.0200.0240.0010.0040.0200.0240.0030.004H120 (FJ888351-China)0.0200.0240.0010.0040.0200.0240.0030.004H120 (KF188436-India)0.0190.0220.0010.0020.0190.0220.0020.002H120 (GU393335-USA)0.0200.0220.0010.0020.0200.0220.0020.002H120 (KR605489-Iran)0.0210.0240.0020.0040.0210.0240.0010.000W93 (AY842862-China0.0220.0280.0030.0070.0220.0280.0050.007D41 (AH014596-China)0.0220.0300.0040.0090.0220.0300.0060.009HK (AY761141-China)0.0200.0240.0020.0070.0200.0240.0040.007H94 (DQ515801-China)0.0220.0280.0030.0070.0220.0280.0050.007IBN (AY856348-China)0.0210.0260.0020.0060.0210.0260.0040.006Ma5 (KY626045-Brazil)0.0190.0240.0010.0000.0190.0240.0040.004Mass commercial vaccine (EU359657-USA)0.0010.0020.0200.0230.0010.0020.0210.023H52 (EU817497-China)0.0190.0300.0090.0170.0190.0300.0100.013M41 (MK937830-China)0.0180.0340.0250.0390.0180.0340.0250.037[^1][^2]

Interestingly, the S1 amino acid sequence of strain I1124/16 was identical to that of the Thailand strain, THA280252, and 14 Mass-type strains (PDRC_110032, MDL_15-1778, MDL_15-2415, MDL_15-5589, MDL_15-6409, PDRC_109841, PDRC_109842, PDRC_109927, PDRC_110029, PDRC_110149, PDRC_110177, PDRC_110263, PDRC_110327, and PDRC_111337), which were isolated in America.

Complete genomic characteristics of the four field strains {#sec3.2}
----------------------------------------------------------

The complete genome lengths of strains LJL/130906, LJL/140820, I1124/16, and I0603/17 were 27459, 27630, 27463, and 27627 bp, respectively ([Supplementary Table S1](#appsec1){ref-type="sec"}). The four IBV strains had a typical IBV genome organization consisting of: 5′ UTR, ORF1a/ab, S glycoprotein, ORF3a, ORF3b, E protein, M protein, ORF 4b, ORF 5a, ORF 5b, N protein, 3′ UTR, and a poly (A) tail.

The phylogenetic trees constructed with complete genomic sequences revealed that the IBV strains, LJL/140820 and I0306/17, were clustered together with the different H120 and Ma5 vaccine strains (H120-clade), whereas the LJL/130906 and I1124/16 strains were separated from both H120-clade and M41-clade ([Figure 1](#fig1){ref-type="fig"}B). Comparatively, the LJL/130906 and I1124/16 strains were genetically closer to the M41-clade than that of the H120-clade. Both clades in which our four strains were included are clearly distinct from the H52, Mass41 vaccine, Mass41 2006, Beaudette, and viruses derived from the recombination between H120 and other IBV types ([@bib30]; [@bib14]; [@bib20]; [@bib19]). Consistently, isolates LJL/140820 and I0306/17 displayed highly similar genomic patterns with those of viruses in the H120-clade using MAFFT and SimPlot analyses; however, the LJL/130906 and I1124/16 strains were clustered with viruses of the M41-clade ([Supplementary Figs. 3A and 3B](#appsec1){ref-type="sec"}).

Isolates LJL/140820 and I0306/17 may be derived from vaccine strains {#sec3.3}
--------------------------------------------------------------------

The results from MAFFT showed that the genomic sequence of isolate LJL/140820 showed high identity to that of Ma5, however, the genomic sequence of isolate I0603/17 showed high identity to that of the H120 vaccine strain ([Figure 2](#fig2){ref-type="fig"} ). Only 10 nucleotide mutations were found across the genomes between LJL/140820 and Ma5 strains. However, 47, 885, and 2441 mutations were found between LJL/140820 and H120, H52, and M41, respectively. For isolate I0603/17, 34, 53, 876, and 2447 nucleotide mutations were found when compared to H120, Ma5, H52, and M41 strains, respectively. Taken together, these results show that the LJL/140820 isolate was possibly a re-isolated Ma5 strain and I0306/17 may derived from the H120 vaccine strain.Figure. 2Analysis of the complete genomic sequences of our four IBV strains with those of H120, Ma5, and M41 strains by using MAFFT. Nucleotide sequence disagreement at the indicated positions is shown in black, whereas the nucleotide sequence agreement is shown in gray. The GenBank accession numbers are shown at the end of the name of the viruses. The numbers indicate the genomic position at the top of the figure.

Isolate I1124/16 is likely a variant of the M41 strain {#sec3.4}
------------------------------------------------------

Comparative genomic analyses revealed that the I1124/16 strain had the highest genome similarity with the LJL/130906 strain, sharing 98.4% overall nucleotide identity, compared to that of M41 (97.0%), H52 (93.1%), H120 (91.4%), and Ma5 (91.4%). These results were confirmed by an MAFFT analysis, which showed that the I1124/16 and LJL/130906 strains had comparatively similar patterns to each other and to that of the M41 strain, compared to the H120 and Ma5 vaccine strains ([Figure 2](#fig2){ref-type="fig"}).

To identify possible recombinant events, SimPlot analyses were performed on the genomes of the I1124/16 strain with that of the M41 strain, and the H120 genomic sequence used as a query ([Figure 3](#fig3){ref-type="fig"} A). Two regions (I and III) which showed relatively high diversity to the M41 strain were identified in the I1124/16 genome. However, these two regions still displayed a close relationship with other Mass-type viruses by a BLAST search in the NCBI database. In addition, bootscan did not identify an obvious potential recombination in the genome of the I1124/16 strain. These results suggest that the I1124/16 strain is a variant M41 strain that resulted from accumulated mutations after passaging in vaccinated chickens.Figure. 3MAFFT, Simplot, and bootscan analyses were used to detect the genetic relationship of the complete genomes of isolates I1124/16 (A) and LJL/130906 (B). Nucleotide sequence disagreement at the indicated positions is shown in black, whereas the nucleotide sequence agreement is shown in gray in the MAFFT. The complete genomic sequence of the H120 strain (GenBank no. MK937831) was used as the query in the SimPlot and bootscan analysis. The window width and step size in SimPlot were set to 500 bp and 50 bp, respectively. Different regions in the genome of the isolates I1124/16 (I-IV) and LJL/130906 (I-III) showed different degrees of diversity. The hollow boxes indicate the different fragments in the bootscan analysis.

Strain LJL/130906 isolate is a mosaic {#sec3.5}
-------------------------------------

One region (II) which showed a relatively high diversity with the I1124/16 strain were identified in the LJL/130906 genome by SimPlot analyses. A BLAST search in the NCBI database showed that sequences in region II of the LJL/130906 showed a higher close genetic relationship with the Conn-type viruses (Connecticut vaccine) (99% nucleotide identity). Further analysis using SimPlot and bootscan identified obvious recombination events in the genomic sequence of LJL/130906 when compared with those of M41, I1124/16, and Connecticut vaccine strains ([Figure 3](#fig3){ref-type="fig"}B). Thus, LJL/130906 might originate from recombination events between the I1124/16- and Connecticut-like strains. Two major recombination events were observed, one in the 5′ end of nsp 4 (approximately at nucleotides 8,848 to 8,853) and another in the 5′ end of nsp12 (approximately at nucleotides 14,963 to 15,053) (Supplemental Figure 2).

We also compared the sequences of LJL/130906 from the 5′ end of nsp 4 to the 5′ end of nsp 12 with those of the Connecticut vaccine and four Conn-type field strains (Conn46 1966, Conn46 1972, Conn46 1983, and Conn46 1991), and did not identify whether the LJL/130906 strain was genetically closely related to the Connecticut vaccine or to four Conn-type field strains (Supplementary Table S2).

Antigenicity between the six Mass-type IBV strains {#sec3.6}
--------------------------------------------------

The neutralization capacity of each antiserum was evaluated based on the viral replication by RT-PCR in embryonated chicken eggs inoculated with a virus-serum mixture, and the R value was calculated to evaluate the antigenic relatedness between viruses. The R value of homologous virus-serum was standardized to 100. The results showed that different Mass-type strains possess R values between 68.8 (I0306/17 and M41) and 85.6 (I1124/16 and LJL/130906) ([Table 2](#tbl2){ref-type="table"} ). Comparatively, higher R values were shared between I0306/17, LJL/140820 and H120, comparing to those of other isolates, which were in line with the results of S1 and complete genomic identities between IBV these IBV strains. However, isolates I1124/16 and LJL/130906 showed high R value (85.6) between each other but slight lower R values to the M41 and H120, suggesting difference in the antigenicity between the two isolates, and M41 and H120, although they belong to the same serotype. Hence, strain I1124/16 was used for further pathogenic and vaccination-challenge tests.Table 2The R values between Mass-type IBV strains used in this study.StrainR valueI1124/16LJL/130906I0306/17LJL/140820H120M41**I1124/16**10085.667.468.572.476.0**LJL/130906**10070.271.668.874.1**I0306/17**10079.878.668.4**LJL/140820**10082.269.8**H120**10066.2**M41**100

The virulence of isolate I1124/16 was comparable to that of pathogenic M41 {#sec3.7}
--------------------------------------------------------------------------

Clinical signs were observed in seven of the I1124/16-infected chicks (70% morbidity) from post-inoculation days 3 to 9, including listlessness, huddling, and ruffled feathers. The virulence of isolate I1124/16 was comparable but slightly lower than that of the pathogenic M41 strain (90% morbidity) to 21-day-old SPF chickens, as evaluated by the scores of clinical signs ([Figure 4](#fig4){ref-type="fig"} A). None of the chicks died during the experiment in both the I1124/16- and M41-infected groups. Chicks infected with I1124/16 and M41 were negative for IBV antibody at 4 dpi and approximately 50% of birds were positive at 8 dpi. All the birds were antibody positive at 8 dpi onwards in both group. No antibody was detected in the birds of negative group.Figure. 4The vaccination-challenge test. The mean score was calculated from individual scores that were based on severity of respiratory signs detected in individual chickens (A). The virus recovery from tracheal swabs collected from H120-vaccinated chickens at different time points after challenge with isolate I1124/16 and strain M41, comparing with those of the non-vaccinated and challenge chickens (B).

Protection of vaccination with H120 against challenge of isolate I1124/16 {#sec3.8}
-------------------------------------------------------------------------

No clinical signs were observed in any of the birds in the two H120-vaccined groups after challenge with isolate I1124/16 and strain M41, comparing to those of non-vaccinated and challenged birds ([Figure 4](#fig4){ref-type="fig"}B). In terms of the viral shedding in trachea, 100% of chicks vaccinated with H120 had not provided protection at 4 days against challenge of isolate I1124/16, however, only 10% of birds vaccinated with H120 shed viruses in trachea after challenge with M41 strain. Furthermore, there are 40% of H120 vaccinated birds shed virus in trachea at 8 days after challenge with I1124/16, suggested only partial protection was provided with H120 vaccination.

Discussion {#sec4}
==========

An IBV infection is one of the most important threats to the poultry industry in China despite extensive vaccination programs ([@bib17]). Constant molecular surveillance indicated that at least 16 lineages of IBV strains, as well as a number of recombinants are currently circulating in China ([@bib40]). GI-1/Mass IBV is one of the most important serotypes/lineages, although Mass-type vaccines (e.g., H120, H52, and Ma5) are extensively used to control and prevent IBV outbreaks in China. The four Mass-type IBV strains in this study were isolated from the H120-vaccinated chickens between 2013 and 2017 in China. Although the four strains were genetically close to the H120 and Ma5 vaccines based on the results of S1 phylogeny analysis, they showed slightly different patterns in the phylogenetic trees, and deep investigation into the complete genomes of the LJL/140820 and I0306/17 strains using phylogenetic analysis, MAFFT, and a pairwise comparison suggested that LJL/140820 was most closely related to the Ma5 vaccine strain and I0306/17 exhibited a close relationship with the H120 vaccine strain. Further analysis showed that multiple nucleotide point mutations were observed between the genomes of I0306/17 and H120 strains, which suggests that the I0306/17 strain might have resulted from accumulated point mutations after several passages in chickens, as previously reported ([@bib30]; [@bib14]). The fact that the Mass-type viruses were isolated from clinically diseased chickens indicates that vaccine-derived viruses have likely acquired the necessary sequence changes for pathogenicity ([@bib34]) and returned to a wild-type pathogenic state ([@bib33]).

The S1 sequences of the isolates LJL/130906 and I1124/16 showed obvious point mutations when compared with those of the M41 and H120 strains ([@bib47]), however, other genes and regions were found to be affected by mutations in the genomes of Mass-type strains which was consistent with previous observations ([@bib4]). It is important to note that the sequence of the S1 subunit in the isolate I1124/16 was identical to that of the 14 Mass-type IBV strains in America and a Thailand strain. We cannot conclude that the I1124/16 strain originated from the 15 Mass-type IBV strains or vice versa because no additional information is available regarding these strains. However, the present results suggest that the I1124/16 strain and the 15 strains might share the same ancestor, and the evolutionary path of strain I1124/16 was different from that of the LJL/140820 and I0306/17 strains. Comparatively, the I1124/16 strain was more closely related to the M41 strain than the H120, H52, and Ma5 vaccine strains, however, point mutations were found to be scattered across the genome of the I1124/16 strain when compared with that of the M41 strain. IBV M41 is a virulent respiratory IBV strain ([@bib44]) and the M41-like virus is detected at a low frequency in chicken flocks ([@bib14]). We hypothesized that the I1124/16 strain might have resulted from an accumulation of point mutations in the M41 strain when it spread in chickens in the presence of Mass specific antibody; thus, it was a M41 variant. The results of the VN test revealed that the I1124/16 strain was antigenically related but different from the M41, which consistent with the minor genetic differences in the S1 genes between them. Changes in the antigenicity is likely caused by S1 variability since it has been well-established that even a small change in the amino acid sequence of the spike protein can result in the antigenic changes ([@bib36]; [@bib13]).

The Mass lineage virus is the current industry standard vaccine strain for IBV control. Our results from the protection experiments pointed out that chickens immunized with H120 virus failed to eliminate viral shedding after infection with the isolate I1124/16. This results were consistent to the field observation because the I1124/16 was isolated from H120-vaccinated diseased flock. Furthermore, the virus produced appreciable pathogenic effects in the immunized chickens, indicating that H120 vaccine may not confer full cross-protection against the variant IBV isolate. It has been reported that there is an increased likelihood of a high level of cross-protection between strains with high nucleotide identity when compared to strains with a low homology. However, this correlation is not considered to be strong ([@bib18]) because strains which differed only by a few per cent in nucleotide similarity were associated with a significant drop in cross-protection ([@bib35]; [@bib1]). Thus, more studies based on the reverse genetic techniques are needed to elucidate the amino acids found in the S1 subunit possibly contributing to the altered antigenicity of the isolate I1124/16 comparing to M41 strain, as illustrated by the VN and vaccination-challenge tests. IBV pathogenicity was shown to be polygenic, involving both the spike and replicase proteins ([@bib21]; [@bib5]; [@bib7]; [@bib38]). The I1124/16 was found to have comparable but slightly lower pathogenicity with M41 strain. Hence, the amino acid substitutions in the S1 subunit of I1124/16 is likely to be of little or no consequence to the pathogenicity.

A unique mechanism of RNA synthesis involving polymerase jumping and discontinuous transcription might be responsible for recombination in coronaviruses ([@bib24]). Moreover, the occurrence of multiple recombination events has been reported to be related to Mass-type IBV strains, between field strains ([@bib14]), between vaccine strains ([@bib28]), and between field and vaccine strains ([@bib30]; [@bib28]; [@bib14]), either within the same genotype (intra-genotypic) or different genotypes (inter-genotypic). The present findings indicate that LJL/130906 has undergone intra-genotypic recombination between an M41 variant and Conn-type virus. Although the Conn-type field strain has not been detected in China to date, a recombinant IBV between H120 and the Connecticut vaccine has previously been detected ([@bib28]). It is possible that the Connecticut vaccine was involved in the emergence of the LJL/130906 strain because the Mass-Conn bivalent vaccine is used extensively throughout China; however, we did not find any direct evidence. The two identified recombination sites are located at the 5′ ends of nsp 4 and nsp12 of LJL/130906, respectively, which are not within the intergenic regions previously reported as recombination 'hot spots' ([@bib25]).

The results of the present study show multiple patterns of the spread of GI-1/Mass-type IBV field strains in China. These different Mass-type IBV strains may evolve independently from each other. The differences of the field conditions, and genetic pressures between different flocks likely account for these evolution of the viruses although the successful spread of the GI-1/Mass-type IBVs is associated, at least in part, with the use of vaccines. These findings underscore the need for continuous surveillance to provide a better understanding of GI-1/Mass-type IBV molecular diversity. The GI-1/Mass-type is among the most prevalent and economical important IBV lineages worldwide; thus, the genetic and antigenic results obtained in this study are significant because these results extend our knowledge of the GI-1/Mass-type IBV strains and may potentially provide relevant elements to improve control programs.
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[^1]: The first 1620 nucleotides, starting at the AUG translation start codon, of the S1 protein genes were compared.

[^2]: NT = nucleotide; AA = amino acid.
